Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Propel Bio Management, LLC (CIK 1969764) reported $158.7M across 36 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: PAGP ($30.2M, 19.02%), ACHV ($11.4M, 7.17%), PHAT ($9.4M, 5.90%), DCTH ($9.2M, 5.77%), CORT ($6.0M, 3.80%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PAGP | PLAINS GP HLDGS L P | $30.2M | 19.02% | 1.3M | Hold |
| 2 | ACHV | ACHIEVE LIFE SCIENCES INC | $11.4M | 7.17% | 3.8M | Hold |
| 3 | PHAT | PHATHOM PHARMACEUTICALS INC | $9.4M | 5.90% | 841,272 | Added |
| 4 | DCTH | DELCATH SYS INC | $9.2M | 5.77% | 979,698 | Added |
| 5 | CORT | CORCEPT THERAPEUTICS INC | $6.0M | 3.80% | 147,828 | New |
| 6 | ABEO | ABEONA THERAPEUTICS INC | $6.0M | 3.79% | 1.3M | Added |
| 7 | KYTX | KYVERNA THERAPEUTICS INC | $5.6M | 3.52% | 644,421 | Trimmed |
| 8 | VOR | VOR BIOPHARMA INC | $5.6M | 3.52% | 314,543 | New |
| 9 | MIST | MILESTONE PHARMACEUTICALS IN | $5.1M | 3.20% | 4.1M | Hold |
| 10 | CLDX | CELLDEX THERAPEUTICS INC NEW | $4.1M | 2.61% | 131,364 | Trimmed |
| 11 | CMPS | COMPASS PATHWAYS PLC | $4.1M | 2.60% | 742,049 | Trimmed |
| 12 | VRDN | VIRIDIAN THERAPEUTICS INC | $4.1M | 2.58% | 210,163 | Trimmed |
| 13 | IVA | INVENTIVA SA | $4.0M | 2.52% | 724,678 | Trimmed |
| 14 | SABS | SAB BIOTHERAPEUTICS INC | $3.9M | 2.45% | 1.0M | Added |
| 15 | OBIO | ORCHESTRA BIOMED HLDGS INC | $3.8M | 2.41% | 896,701 | New |
| 16 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $3.6M | 2.26% | 380,420 | New |
| 17 | OCS | OCULIS HOLDING AG | $3.3M | 2.07% | 122,223 | Trimmed |
| 18 | OCUL | OCULAR THERAPEUTIX INC | $3.2M | 2.03% | 382,375 | New |
| 19 | UPB | UPSTREAM BIO INC | $3.1M | 1.95% | 341,779 | New |
| 20 | AQST | AQUESTIVE THERAPEUTICS INC | $3.0M | 1.86% | 710,988 | New |
| 21 | EYPT | EYEPOINT INC | $2.8M | 1.76% | 215,825 | New |
| 22 | TRVI | TREVI THERAPEUTICS INC | $2.6M | 1.67% | 223,802 | New |
| 23 | ZVRA | ZEVRA THERAPEUTICS INC | $2.6M | 1.66% | 282,418 | Added |
| 24 | IMUX | IMMUNIC INC | $2.6M | 1.65% | 2.3M | New |
| 25 | CHRS | COHERUS ONCOLOGY INC | $2.4M | 1.52% | 1.4M | New |
Source: SEC Form 13F filings · as of 2026-03-31